# A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

> **NCT06822868** · PHASE1 · RECRUITING · sponsor: **Kai Hu** · enrollment: 24 (estimated)

## Conditions studied

- B-Cell Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** CAR T cells

## Key facts

- **NCT ID:** NCT06822868
- **Lead sponsor:** Kai Hu
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-10
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06822868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06822868, "A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06822868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*